The Pulse by Wharton Digital Health The Pulse by Wharton Digital Health

In this episode, I sat down with Dr. Neel Shah, Chief Medical Officer of Maven Clinic, the world’s largest digital clinic for women’s and family health.

Dr. Shah is a practicing obstetrician and a visiting scientist at Harvard Medical School where he previously served as a professor of obstetrics, gynecology, and reproductive biology. Dr. Shah joined Maven in 2021 with a mission to expand and diversify women’s and family health practices. He is a big advocate for health equity and reproductive justice with numerous awards and media recognitions for his impact on maternal health in the United States.



In this episode, Neel and I discussed:


The fertility industry has evolved rapidly, with new technologies and a more inclusive approach to care outcomes and reducing overutilization.
Health equity is a critical issue in women’s healthcare, and Maven is actively working to address disparities and provide culturally humble care.
How Maven integrates cultural humility into its care delivery and medical practice design to ensure patients feel seen and heard.
Maven’s expansion into Medicaid demonstrates its commitment to accessible and equitable healthcare for all.

In this episode, I sat down with Jared Dauman, co-founder and Head of Operations for Soda Health. Founded in 2021, Soda Health is a healthcare technology company focused on reducing health inequities. Soda Health uses technology to simplify healthcare transactions, similar to retail purchases, using debit cards. This approach aims to bridge the gap between medical claims and retail payments, ensuring consumers have easier access to benefits. In this episode, Jared and I discuss his journey from working in the directed spend space at Walmart to becoming a co-founder of Soda Health, the business model of Soda Health, the integration of fintech and healthcare, the challenges and opportunities in the world of digital health partnerships, and the evolving role of social determinants of health interventions.

Founded in 2017, Paige is a digital pathology software provider that uses AI to improve cancer diagnoses. Paige was the first ever company to earn FDA approval for an AI-based product, and they are currently collaborating with Microsoft to build the world’s largest image-based AI cancer model. In this episode, Dr. Moye and I discuss Paige’s origin as a spin-out from Memorial Sloan Kettering, the role of AI in supporting cancer diagnostics, the process of navigating corporate partnerships and FDA approval with AI tools, and the value of new AI applications in healthcare.

In this episode, I sat down with Buck Poropatich, Head of Lyft Healthcare. Lyft Healthcare launched in 2016 as part of Lyft's broader efforts to address transportation barriers in healthcare. Today, Lyft Healthcare partners with 9 of the 10 largest US health systems, non-emergency medical transportation brokers, and the top 10 payers to provide rides across the patient journey.

By providing reliable transportation through its extensive network, Lyft Healthcare helps reduce patient no-shows, enhance the member experience, and ultimately improve patient outcomes. Since he joined in 2019, Buck has helped secure key partnerships with industry leaders like ChenMed, CVS, and Kroger Health, alongside countless others. 

Buck and I discussed: 


Lyft Healthcare’s founding story after the company discovered a hidden product-market fit in the healthcare industry.
Creative partnerships with companies like Best Buy Health and Instacart Health that have enhanced Lyft Healthcare's services and expanded their reach in the healthcare space.
Lyft Healthcare’s alignment with the shift towards value-based care, as transportation plays a strategic role in improving care adherence, member satisfaction, and managing total cost of care.
Future expansion plans for Lyft Healthcare include expanding their Medicaid footprint, extending their Lyft Assisted product, and leveraging mobile app technology and data modeling to improve the member experience.

Our guest on this episode is Nawal Roy. Nawal Roy is the founder and CEO of Holmusk, a company that specializes in real-world evidence, AI-powered analytics, and digital solutions to solve the evidence gaps problem in mental health.

Last year, Holmusk raised a series B funding round of $45M, led by Veradigm, a leading provider of healthcare data and technology solutions. Powered by this investment, Holmusk’s NeuroBlu database recently reached a pivotal milestone of 4 million patient lives, becoming the largest NLP-enriched, de-identified real-world data platform designed for behavioral health and mental health research. 

Nawal and I discussed:


Holmusk’s founding story, how Nawal connected his background and skill sets in finance to healthcare, and where he saw opportunities in building a “Bloomberg Terminal” for behavioral health 


Holmusk’s flagship platform, Neuroblu, which organizes and analyzes a large volume of real-world data to provide insights for research, care improvement, and marketing purposes


Generative AI and natural language processing (NLP) and their the potential to revolutionize mental health care by enabling precision psychiatry, improving the standardization of treatment protocols, and bridging the evidence gap


Holmusk’s  active partnerships with healthcare systems, pharma companies, and government organizations to expand its data set and drive meaningful change in the industry

Our guests this episode are Dr. Sameer Berry and Sam Holliday, co-founders and CMO and CEO of Oshi Health. Oshi Health is a virtual gastrointestinal care clinic increasing access to care for the one in four Americans with digestive disorders. In this episode, I spoke with Sameer and Sam about:




Oshi’s high-touch, integrated care model for GI patients


Purpose-built clinical workflows to improve outcomes and cost savings


Oshi's partnerships with independent GI practices and health plans


The future of virtual first specialty care